245 related articles for article (PubMed ID: 12023773)
21. Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans.
Erickson AL; Walker CM
J Gen Virol; 1993 Apr; 74 ( Pt 4)():751-4. PubMed ID: 8468558
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of human immunological responses to vaccinia virus.
Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
[TBL] [Abstract][Full Text] [Related]
24. CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells.
Zaunders JJ; Dyer WB; Munier ML; Ip S; Liu J; Amyes E; Rawlinson W; De Rose R; Kent SJ; Sullivan JS; Cooper DA; Kelleher AD
J Virol; 2006 Oct; 80(20):10151-61. PubMed ID: 17005692
[TBL] [Abstract][Full Text] [Related]
25. Age-dependent hantavirus-specific CD8(+) T-cell responses in mice infected with Hantaan virus.
Araki K; Yoshimatsu K; Lee BH; Okumura M; Kariwa H; Takashima I; Arikawa J
Arch Virol; 2004 Jul; 149(7):1373-82. PubMed ID: 15221537
[TBL] [Abstract][Full Text] [Related]
26. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
27. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
28. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.
Kim SH; Bang JW; Park KH; Park WB; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
J Infect Dis; 2006 Aug; 194(3):377-84. PubMed ID: 16826487
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
[TBL] [Abstract][Full Text] [Related]
30. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus.
Piriou L; Chevallier S; Hutet E; Charley B; Le Potier MF; Albina E
Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856
[TBL] [Abstract][Full Text] [Related]
31. Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees.
Tenorio AR; Peeples ME; Patri M; Rezai K; Trenholme GM
Clin Diagn Lab Immunol; 2004 Jul; 11(4):758-61. PubMed ID: 15242952
[TBL] [Abstract][Full Text] [Related]
32. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
33. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
34. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
35. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
[TBL] [Abstract][Full Text] [Related]
36. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
Bartlett JG
Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
[TBL] [Abstract][Full Text] [Related]
37. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer.
Wiser I; Orr N; Kaufman B; Segev S; Smetana Z; Bialik A; Epstein N; Mendelson E; Catane R; Cohen D
J Infect Dis; 2010 May; 201(10):1527-34. PubMed ID: 20388035
[TBL] [Abstract][Full Text] [Related]
39. Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine.
Rock MT; Yoder SM; Talbot TR; Edwards KM; Crowe JE
J Infect Dis; 2006 Aug; 194(4):435-43. PubMed ID: 16845626
[TBL] [Abstract][Full Text] [Related]
40. Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
Kremer M; Suezer Y; Volz A; Frenz T; Majzoub M; Hanschmann KM; Lehmann MH; Kalinke U; Sutter G
PLoS Pathog; 2012; 8(3):e1002557. PubMed ID: 22396645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
